Abstract Two anti-mycobacterial peptides with a lasso structure, named lariatins A and B, were separated by HP-20 and ODS column chromatographies and purified by HPLC from the culture broth of Rhodococcus jostii K01-B0171, which was isolated from soil aggregates collected in Yunnan, China. Lariains A and B showed growth inhibition against Mycobacterium smegmatis with MIC values of 3.13 and 6.25 m g/ml in agar dilution method, respectively. Furthermore, lariatin A inhibited the growth of Mycobacterium tuberculosis with an MIC of 0.39 mg/ml in liquid microdilution method.
Introduction
Our research group has focused on discovery of antiinfectives from microbial metabolites [1ϳ3] . Tuberculosis (TB) is still the greatest single infectious cause of mortality in the world, together with HIV and malaria [4] . Moreover, the spread of the HIV promoted to increase the number of tuberculosis patients [5] . However, powerful anti-TB drugs with a new mechanism of action have not been developed in last over thirty years, and only 5 anti-TB drugs can be clinically used still now. Since isoniazid and ethambutol, first-line anti-TB drugs, show specific inhibition against Mycobacteria, we have screened for new agents from microbial metabolites having specific inhibition against Mycobacterium smegmatis among 16 test microorganisms including Gram-positive and -negative bacteria, fungi and yeasts. As a part of this program, we discovered novel compounds designated lariatins A and B (Fig. 1) , unique cyclic peptides produced by Rhodococcus jostii K01-B0171 (Fig. 2) . These peptides consist of 18 and 20 amino acid residues with an internal linkage between the gcarboxyl group of Glu8 and the a -amino group of Gly1, and the tail region passes through the ring region. (Fig. 3) . The structure elucidation was published elsewhere [6] . In this paper, the taxonomy, fermenation, isolation and physico-chemical and biological properties of lariatins are described. Lariatin A showed growth inhibition against not only M. smegmatis but also Mycobacterium tuberculosis.
Materials and Methods

Isolation of Strain K01-B0171
Soil was collected in Yunnan, China. Isolation method of strain K01-B0171 from soil aggregates was reported in detail elsewhere [7] . In brief, soil aggregates with diameters of 160ϳ990 mm were collected by using filters, and washed with acidic electrolyzed water and sterilized water. The aggregates suspended in sterilized water were then disrupted by a sonicater, and the mixture were spread on Waksman plates to isolate colonies of microorganisms.
Taxonomic Studies
The cultural and physiological characteristics of the strain were determined following the methods recommended by the International Streptomyces Project (ISP [8] ) and Waksman [9] . The utilization of carbon sources was tested by growth on Pridham and Gottlieb's medium containing 1.0% carbon at 27°C [10] . The morphological properties were observed with a scanning electron microscope (model JSM-5600, JEOL). Isomers of diaminopimelic acid (DAP) in whole-cell hydrolysates were determined by the standard methods using TLC [11, 12] , and the N-acyl types of muramic acid were determined by the method of Uchida and Aida [13] . Whole-cell sugars were analyzed [11] , presence of mycolic acids was examined by the TLC method [14] , and phospholipids were extracted and identified by the method of Minnikin et al. [15] . Menaquinones were extracted and purified by the method of Collins et al. [16] , then analyzed by HPLC (model 802-SC, JASCO) on a chromatograph equipped with a CAPCELL PAK C18 column (Shiseido Co.) [17] . The GϩC content (mol%) of chromosomal DNA was determined by the HPLC method of Tamaoka and Komagata [18] . 16S rDNA was amplified by PCR and was sequenced directly on an ABI model 377A automatic DNA sequencer using a PRISM Ready Reaction Dye Primer Cycle Sequencing Kit (Applied Biosystems). The CLUSTAL W software package (Thompson et al. [19] ) was used for multiple-alignment with selected sequences for calculating evolutionary distances (Kimura [20] ) and similarity values and for constructing a phylogenetic tree based on the neighbor-joining method (Saitou et al. [21] ).
Analysis of Lariatin Production by HPLC
The production of lariatins was measured by analytical HPLC under the following conditions: column, Symmetry C18 (2.1ϫ150 mm, Waters Co.); mobile phase, acetonitrilewater with 0.05% phosphoric acid, 0ϳ40% (20 minutes); UV detection at 210 nm; flow rate of 0.2 ml/minute. Lariatins A and B were eluted with retention times of 12.3 and 12.5 minutes, respectively.
General Procedures
The mass spectra were measured with a JOEL JSM-700 MS station and a JOEL JSM-AX 505 HA in thioglycerol. IR spectra were run in KBr on a HORIBA FT-210. The UV spectra were recorded on a HITACHI 340. The optical rotations were measured on a JASCO DIP-1000 Digital Polarimeter with a 5 cm cell. The melting points were measured on a Yanagimoto Micro Melting Point Apparatus MP-S3. Assay for Antimicrobial Activities Antimicrobial activity was measured by paper disk method (6 mm, ADVANTEC) containing a test sample [22] . The culture conditions were followed; Anti-mycobacterial activity was measured by agar dilution method or liquid microdilution method. Agar dilution method: Test organisms were adjusted to approximately 1.0ϫ10 6 CFU/ml, and inoculated using multipoint inoculator (Sakuma). Middlebrook 7H11 agar plates with or without the test compounds were inoculated with the test organisms and incubated for 14 days at 37°C and then examined to determine the MIC for each organism.
Liquid microdilution method: M. tuberculosis H37Rv was adjusted to approximately 1.0ϫ10
6 CFU/ml in Middlebrook 7H9 broth containing 0.05% Tween 80 and 0.5% glycerol. The culture broth (200 m l) was added to each well of a 96-well microplate (Corning) with or without the test compounds. After incubation for 5 days at 37°C, 12.5% Tween 80 (20 m l) and alamarblue (20 m l, Biosource) were added to each well. After overnight incubation at 37°C, the measurement of A 570 and A 600 was carried out to determine the MIC.
Results
Taxonomy of the Producing Strain K01-B0171
Strain K01-B0171 was isolated from a soil sample collected in Yunnan Province, China using the ultrasonic processor from the inside of soil aggregates [7] . Good growth occurred on yeast extract -malt extract agar, tyrosine agar, nutrient agar and others, and no aerial mycelia grew. Color of colonies was orange to brown. Cells were short rods or coccus and were 1.1ϳ1.4ϫ0.7ϳ0.8 mm in size (Fig. 2) . Growth temperature range was 6°C to 37°C. D-Glucose, D-mannitol, D-fructose, L-rhamnose, myoinositol and sucrose were used but L-arabinose, raffinose, melibiose, and xylose were not used as sole carbon. No melanoid pigment was produced.
Strain K01-B0171 contained meso-DAP, arabinose and galactose in whole-cell hydrolysates. The acyl type of the peptidoglycan was glycolyl. The predominant menaquinone was MK-8(H 2 ). Mycolic acids were detected and phosphatidylethanolamine was detected as the phospholipid. The GϩC content (mol%) of the DNA was 66%. These results indicated strain K01-B0171 belongs to the genus Rhodococcus. 16S rDNA sequence (1513 nucleotides) was determined for strain K01-B0171 and the DDBJ accession number is AB204817. The phylogenetic analysis with 16S rDNA database sequences revealed that strain K01-B0171 branched deeply within a member of the genus Rhodococcus and most closely related to Rhodococcus jostii IFO 16295 T [24] (Fig. 4) . As the sequence similarity was high value (99.5%), the strain K01-B0171 should be identified with Rhodococcus jostii. O (pH 7.0 before sterilization). A loopful of spores of Rhodococcus sp. was inoculated into 200 ml of medium in two 500-ml Erlenmeyer flasks on a rotary shaker (210 rpm). The inoculated flasks were incubated at 27°C for 3 days. A 200 ml portion of the culture was transferred to a 30-liter jar fermenter containing 20 liters of the same medium and the fermentation was carried out at 37°C for 4 days. The typical time course of fermentation is shown in Fig. 5 . The production of lariatin A was slowly increased and reached a maximum level of about 90 mg/ml on day 10 after inoculation. The production of lariatin B reached a maximum level of about 60 m g/ml on day 5, thereafter the amount slowly decreased.
Fermentation
Isolation
The procedure for the isolation of lariatins A and B is summerized in Scheme 1. The 4-day old culture broth (16 liters) was centrifuged to separate mycelium and supernatant. The supernatant was passed through a column of Diaion HP-20 (75ϫ220 mm, Nihon Rensui Co.) previously equilibrated with water. After washing with water (3 liters) and 20% acetone (3 liters), the active materials were eluted with 80% acetone (3 liters). The whole eluate was concentrated in vacuo and lyophilized to dryness to yield a brown material (7.2 g). The material was dissolved in water and applied on an ODS column (35ϫ270 mm, Senshu Scientific Co.) previously equilibrated with water. After washing with water (600 ml) and 20% acetonitrile (600 ml), the active materials were eluted with 40% acetonitrile (600 ml). The whole eluate was concentrated in vacuo to dryness to yield a brown material (348 mg). The material was dissolved in a small amount of methanol and passed through a Sephadex LH-20 column (25ϫ1100 mm, Amersham Biosciences Co.). The active fractions were concentrated in vacuo to dryness to yield a brown material (244 mg). The active material was purified by HPLC on a CAPCELL PAK C 18 column (20 i.d.ϫ250 mm, Shiseido Co.) with 22% acetonitrile containing 10 mM phosphate buffer (pH 7.5) at 8 ml/minute detected at UV 210 nm. The retention times of lariatins A and B were 44 and 56 minutes, respectively (Fig. 6) . The active fractions were desalted on an OASIS HLB column (60 mg, Waters Co.) previously equilibrated with water. After washing with water (3 ml), lariatins were recovered with 80% acetonitrile (2 ml), each of which was concentrated in vacuo to dryness to afford lariatin A (38.2 mg) and lariatin B (11.2 mg) as pale yellow powders [6] .
Physico-chemical Properties
The physico-chemical properties of lariatins A and B are summarized in Table 1 The detail condition of HPLC was described in "Results". was dominant in the IR spectra, indicating that these compounds are peptides. From these date, lariatins are found to be novel compounds. The structures were elucidated as shown in Fig. 1 , which was published elsewhere [6] .
Biological Activities
Lariatins A and B showed strong inhibition only against M. smegmatis among 14 microorganisms tested as well as isoniazid on the conventional paper disk assay (Table 2) . Therefore, anti-mycobacterial activity using an agar dilution method was studied. The MIC values of lariatins A and B were 3.13 and 6.25 mg/ml for M. smegmatis Takeo, respectively. Furthermore, in liquid microdilution method, lariatin A inhibited the growth of M. tuberculosis with an MIC value of 0.39 mg/ml.
Discussion
Mycobacteria have a very unique cell wall structure. From the whole genome sequence [25] , there are a number of enzymes involved in biosynthesis of the cell wall. For example, mycolic acids, extremely long fatty acids, form a broad family of more than 500 closely related structures and comprise about 30% of the dry weight of M. tuberculosis, and the microorganism has about 250 distinct enzymes involved in fatty acid metabolism (vs. 50 for E. coli). Isoniazid and ethambutol are first line tuberculosis drug, which inhibit cell wall biosynthesis; isoniazid inhibits mycolic acid synthesis by blockade of Type II fatty acid synthase [26] , and ethambutol inhibits arabinogalactan mycolate synthesis by blockade of arabinosyltransferase [27] . Recently, platensimycin with a very unique structure was isolated as an inhibitor of Fab2 in Type II fatty acid synthase from Streptomyces starin [28] . Interestingly, lariatins show specific inhibition against mycobacterial growth. As described above, the compounds show the similar biological characteristics. They inhibited the growth of not only M. smegmatis but also M. tuberculosis (Table  2) . Therefore, it might be plausible that the target molecule of lariatins lies within the cell wall biosynthetic steps in mycobacteria as well as isoniazid and ethambutol. 
